Literature DB >> 2058395

Autistic symptoms in children with infantile hydrocephalus.

E Fernell1, C Gillberg, L von Wendt.   

Abstract

From a population-based series of children with Infantile Hydrocephalus (IH) 69 patients (mean age 11.7 years) were examined with respect to the occurrence of autistic symptoms. Autistic symptomatology was evaluated according to a modified short Swedish version of the so-called Autism Behavior Checklist. Sixteen of the 69 IH children (23%) reached a score which was considered indicative of autistic symptoms (AS) in the child. This group was compared with the remaining 53 IH children without autistic symptoms (non AS). Significant differences were found between these two groups with respect to aetiological and clinical data. In the AS group 44% were born preterm as compared to 9% in the non AS group. CT scan showed major abnormalities in 64% of the AS children while this was present in 28% in the non AS group. The occurrence of major neuroimpairments--epilepsy, mental retardation and cerebral palsy--was 50%, 88% and 50% in the AS group as compared to 9%, 23% and 19% respectively in the non AS group. It was concluded that the more severe the brain damage in children with IH the more likely that autistic symptomatology would ensue. This implies that specific neuropsychiatric services to these families are required.

Entities:  

Mesh:

Year:  1991        PMID: 2058395     DOI: 10.1111/j.1651-2227.1991.tb11881.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  9 in total

1.  Camk2a-Cre-mediated conditional deletion of chromatin remodeler Brg1 causes perinatal hydrocephalus.

Authors:  Mou Cao; Jiang I Wu
Journal:  Neurosci Lett       Date:  2015-04-27       Impact factor: 3.046

2.  Behavioural problems and autism in children with hydrocephalus : a population-based study.

Authors:  Barbro Lindquist; Göran Carlsson; Eva-Karin Persson; Paul Uvebrant
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02-23       Impact factor: 4.785

3.  Self-esteem in children with infantile hydrocephalus and in their siblings. Use of the Piers-Harris Self-Concept Scale.

Authors:  Elisabeth Fernell; Christopher Gillberg; Lennart von Wendt
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-10       Impact factor: 4.785

Review 4.  PTEN mutations in autism spectrum disorder and congenital hydrocephalus: developmental pleiotropy and therapeutic targets.

Authors:  Tyrone DeSpenza; Marina Carlson; Shreyas Panchagnula; Stephanie Robert; Phan Q Duy; Nell Mermin-Bunnell; Benjamin C Reeves; Adam Kundishora; Aladine A Elsamadicy; Hannah Smith; Jack Ocken; Seth L Alper; Sheng Chih Jin; Ellen J Hoffman; Kristopher T Kahle
Journal:  Trends Neurosci       Date:  2021-10-05       Impact factor: 13.837

Review 5.  Early detection of autism. Diagnostic instruments for clinicians.

Authors:  C Gillberg; V Nordin; S Ehlers
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

6.  Behavioral outcomes of extremely low birth weight children at age 8 years.

Authors:  Maureen Hack; Hudson G Taylor; Mark Schluchter; Laura Andreias; Dennis Drotar; Nancy Klein
Journal:  J Dev Behav Pediatr       Date:  2009-04       Impact factor: 2.225

7.  The light-flash-evoked response as a possible indicator of increased intracranial pressure in hydrocephalus.

Authors:  A Sjöström; P Uvebrant; A Roos
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

8.  Autism spectrum symptoms in children with neurological disorders.

Authors:  Mari Hysing; Maj-Britt Posserud; Christopher Gillberg; Astri J Lundervold; Hilde K Ryland
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-11-12       Impact factor: 3.033

9.  Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.

Authors:  Ksenija Zega; Vukasin M Jovanovic; Zagorka Vitic; Magdalena Niedzielska; Laura Knaapi; Marin M Jukic; Juha Partanen; Roland H Friedel; Roland Lang; Claude Brodski
Journal:  Front Mol Neurosci       Date:  2017-11-09       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.